The hyperimmune response to COVID infection signals severe disease and ARDS. The pathophysiology and therapy are discussed and illustrated with whiteboard animations. 

HAE is a rare genetic disease that results in immunologic attacks that can be life threatening. This program provides HCPs with new clinically relevant data presented at ACAAI 2021 about this rare disease.

This activity will discuss methods for how to address and manage inhibitor development in individuals with hemophilia A and provide information to help clinicans recognize complications and comorbidities that require comprehensive management in aging individuals with hemophilia A.

 Brush up on your assessment, treatment, and management of patients with pain – to provide the most appropriate care, balancing the risks and benefits of treatment.   

Evaluate clinical trial findings investigating the role of gene therapy in patients with hemophilia A and B

Discuss online resources to identify treatment options for rare genetic disorders that can present in the neonatal period

Join Drs. Badowski and Sosman for this lively discussion to engage in a clinical practice-focused update on the treatment of persons living with HIV (PLWH)

This interactive activity will present an up-to-date guide to optimal recognition and management of influenza in the complex COVID-19 era, with an emphasis on the appropriate uses of antiviral therapy in patient populations who are at high risk for influenza-related complications.